Rami Levin
President, CEO & DirectorMr. Rami Levin, M.B.A. Director of CNS Pharmaceuticals, Inc. from December 2025 and serves as its President & CEO since January 01, 2026. Mr. Levin served as President at Saniona AB (publ) since January 7, 2020 and had been its Chief Executive Officer since January 7, 2020 until April 30, 2022. He has been Vice President of Marketing, Neurodegenerative Diseases and Rheumatology at EMD Serono, Inc. since June 14, 2012. He is a seasoned biotech leader with experience in rare diseases and CNS. In his recent role as President of Sobi Inc., an international specialty biopharmaceutical company dedicated to rare diseases, he was responsible for building the organization, setting its vision, developing strategic growth pillars and leading it through a period of ten-fold growth. As part of that, he led the launch of Gamifant?, the first ever approved treatment for primary hemophagocytic lymphohistiocytosis (pHLH) and the integration of the team behind Synagis, the only approved treatment for respiratory syncytial virus (RSV). Mr. Levin has been with Merck Serono since 1998. He served as Chairman and Managing Director of Merck AB in Sweden and Iceland. He served as Global Marketing Director for Neurology at Merck Serono, Geneva and as the Global Product Manager for Rebif. Mr. Levin began his career as a Business Unit Manager in Neurology at Serono Israel. He worked at Schering AG Israel as both a Product Manager and Sales Representative for Neurology Team. Mr. Levin has a BS in Biology from Tel Aviv University and an MBA, majoring in International Marketing, from Recanati Business School at Tel Aviv University.
Positions
- Company NameCNS Pharmaceuticals, Inc.Stock CodeCNSPPositionPresident, CEO & DirectorColleagues
- FLFaith L. CharlesIndependent Chairman of Board
- SOSteve O’LoughlinChief Financial Officer
- EFEric FaulknerChief Technology Officer
- DWDylan WenkeChief Business Officer
- ELE. Lynne KelleyChief Medical Officer
- JRJeffry R. KeyesIndependent Director
- BMBettina M. CockroftIndependent Director
- AMAmy MaheryIndependent Director
